—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
JOURNAL OF IMMUNOTHERAPY《免疫治疗杂志》
年9期 - 美国
  • JOURNAL OF IMMUNOTHERAPY《免疫治疗杂志》
  • SCIE外文期刊
  • 期发文量6
  • 国人占比36.84%
  • 维普目次
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:4区
    OA期刊:混合
  • 综述期刊:
    TOP期刊:
  • 期均国文:2
    环比增速:-75.00%
  • 期刊信息

  • 研究方向:医学-IMMUNOLOGY 免疫学-MEDICINE, RESEARCH EXPERIMENTAL 医学:研究与实验;ONCOLOGY 肿瘤学
  • 国际刊号:ISSN1524-9557;EISSN1537-4513
  • 期刊语言:英语
    出版地区:美国
  • 投稿网址:https://www.editorialmanager.com/jit/
  • 电子邮箱:
  • 期刊官网:https://journals.lww.com/immunotherapy-journal/pages/default.aspx
  • 作者指南:
  • 出版商网址:http://www.lww.com/
  • 出版地址:LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621
  • 期刊简介:JOURNAL OF IMMUNOTHERAPY《免疫治疗杂志》(一年9期). Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer biology and therapy. Laboratory and preclinical studies, as well as investigative clinical reports, are presented. The journal emphasizes basic mechanisms and methods for the rapid transfer of technology from the laboratory to the clinic. JIT contains full-length articles, review articles, and short communications.

  • 万维提示






  • 1、投稿方式:在线投稿

    2期刊网址:

    https://journals.lww.com/immunotherapy-journal/pages/default.aspx

    3投稿网址:https://www.editorialmanager.com/jit/

    4、官网邮箱:Patrick.wall@wolterskluwer.com(总编)

    5、官网电话:215-521-8421(总编)

    6、期刊刊期:一年出版9期。

    2021年8月17日星期

                                     

     

    投稿须知【官网信息】

     

    Instructions for Authors

    SCOPE

    Journal of Immunotherapy is a peer reviewed, multidisciplinary journal directed to an audience of immunotherapy and biological therapy physicians and researchers. The journal publishes original articles in the form of basic studies, clinical studies, and selected abstracts from scientific meetings and conferences.

    Instructions for Authors (this page)

    Reprint Ordering

    Permissions Requests

    Reprints

    Ethical/Legal Considerations

    A submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher. All manuscripts must be submitted on-line through the journal's Web site at http://editorialmanager.com/jit. See submission instructions below, under "On-line manuscript submission."

    Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.

    Copyright: All authors must sign a copy of the Journal's "Authorship Responsibility, Financial Disclosure, and Copyright Transfer" form and submit it at the time of manuscript submission.

    ……

    更多详情:

    https://edmgr.ovid.com/jit/accounts/ifauth.htm







欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码